In summary, KDM1A can upregulate the Wnt/β-catenin signaling pathway in thyroid cancer cells by suppressing the ubiquitin-proteasome degradation of β-catenin and its regulation on APC2 and DKK1 may contribute to this process. This evidence concerns the gene KDM1A and thyroid gland carcinoma.